Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $3.23 USD
Change Today +0.15 / 4.87%
Volume 1.9M
GERN On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

John A. Scarlett M.D.

Chief Executive Officer, President and Director,Geron Corporation
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. John A. Scarlett, M.D., has been the Chief Executive Officer of Geron Corporation since September 2011 and has also been its President since January 5, 2012. Dr. Scarlett served as Chief Executive Officer and President of Onyx Therapeutics, Inc. since February 2009. He Co-Founded Ipsen Biopharmaceuticals, Inc. (Formerly Tercica Inc) in 2002 and served as its Chief Executive Officer since February 2002. Dr. Scarlett has been Chief Executive Officer and President of ...

Read Full Background

Corporate Headquarters*

149 Commonwealth Drive
Menlo Park, California 94025

United States

Phone: 650-473-7700
Fax: 650-473-7750

Board Members Memberships*

Chief Executive Officer, President and Director


Earlham College
University Of Chicago - Pritzker School Of Medicine

Other Affiliations*

Annual Compensation*

Total Annual Compensation$656,880

Stock Options*

All Other Compensation$60,807
Exercisable Options2,031,980
Exercisable Options Value$2,560,526
Unexercisable Options2,153,020
Unexercisable Options Value$1,803,674
Total Value of Options$4,364,200
Total Number of Options4,185,000

Total Compensation*

Total Annual Cash Compensation$1,069,587
Total Short Term Compensation$656,880
Other Long Term Compensation$60,807
Total Calculated Compensation$6,071,003
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GERN:US $3.23 USD +0.15


Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
Olav Hellebo Chief Executive Officer and Director
ReNeuron Group plc
225.0K GBP
Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
Paul K. Wotton Ph.D.Chief Executive Officer, President and Director
Ocata Therapeutics, Inc.
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, General Counsel and Director
Neuralstem, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GERON CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at